Unveiling mitochondrial and ribosomal gene deregulation and tumor microenvironment dynamics in acute myeloid leukemia

C Ma, Y Hao, B Shi, Z Wu, D Jin, X Yu, B Jin - Cancer Gene Therapy, 2024 - nature.com
… -trait correlation analyses on CD56 bright CD16 − NK cells (E) and CD56 dim CD16 + NK …
High-level leukocyte cell adhesion molecules (ALCAM) were found to be expressed on DCs, …

Orbital myeloid sarcoma misdiagnosed for subperiostal hematoma: a case report

B Razem, M Raiteb, S El Mrini, F Slimani - Journal of Medical Case …, 2021 - Springer
… with, or after the diagnosis of acute myeloid leukemia or other … MS can represent a complication
of different myelodysplastic … The blast neural adhesion molecule (CD56) may have a role …

… with myelodysplastic syndrome or secondary acute myeloid leukaemia evolving from myelodysplastic syndrome undergoing allogeneic haematopoietic stem-cell …

L Xuan, M Dai, E Jiang, Y Wang, F Huang… - The Lancet …, 2023 - thelancet.com
myelodysplastic syndrome or secondary acute myeloid leukaemia evolving from myelodysplastic
… of patients with myelodysplastic syndrome and acute myeloid leukaemia. Therefore, …

Mutational spectrum and associations with clinical features in patients with acute myeloid leukaemia based on next-generation sequencing

Y Li, X Lv, X Ge, D Yuan, M Ding… - Molecular …, 2019 - spandidos-publications.com
cell growth factor receptor Kit (CD117), MPO, HLA-DR, neural cell adhesion molecule 1 (CD56
SETBP1, which is recurrent in myelodysplastic syndromes (MDS) and often co-exists with …

[PDF][PDF] Modelling and targeting Acute Myeloid Leukaemia (AML) cells in the Bone Marrow (BM) protective niche.

EE Ladikou - 2023 - research.brighton.ac.uk
… stem cell transplantation AML Acute myeloid leukaemia AML-MR AML- myelodysplasia-…
oncogene homolog NRM Non-relapse mortality NRCAM Neuronal cell adhesion molecule

[PDF][PDF] Current developments and hurdles in CAR-T cell therapy for acute myeloid leukaemia

L Van Camp, T Lammens, A Uyttebroeck… - BELGIAN JOURNAL …, 2021 - biblio.ugent.be
… Another promising target is the neural cell adhesion molecule 1 (NCAM-1), also known as
CD56, with expression in almost 20% of all AML patients. NCAM-1 is an important regulator of …

Engineering tandem CD33xCD146 CAR CIK (cytokine-induced killer) cells to target the acute myeloid leukemia niche

G Alberti, C Arsuffi, A Pievani, D Salerno… - Frontiers in …, 2023 - frontiersin.org
… Among the possible targets, Melanoma Cell Adhesion Molecule (MCAM)/CD146 represents
a … + T lymphocytes expressing CD8 and CD56 and display an effector memory phenotype. …

Acute myeloid leukaemia in the Johannesburg public sector: A laboratory-based study

J Vaughan, K Hodkinson - SA Journal of Oncology, 2024 - journals.co.za
… )), aberrant CD56 expression (in APL and t(8;21)), Background: Acute myeloid leukaemia
(… Acute myeloid leukaemia myelodysplasia-related occurred at a median age of 54 years (IQR…

[HTML][HTML] Identification of prognostic genes in the acute myeloid leukemia microenvironment

S Huang, B Zhang, W Fan, Q Zhao, L Yang… - Aging (Albany …, 2019 - ncbi.nlm.nih.gov
… CXCR4 and adhesion molecules such as E-selectin and VLA-4 have been targeted to … High
ITGAM/CD56 co-expression combined with low Smac/DIABLO expression were proposed to …

Diagnosis and Classification of AML: WHO 2016

MT Voso, E De Bellis, T Ottone - Acute Myeloid Leukemia, 2021 - Springer
… of myelodysplastic syndrome (MDS) or a myelodysplastic/… least 50% of dysplastic cells in
two or more myeloid lineages. The … Approximately 10% of APL cases express CD56, which has …